If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Global Grwth Regulatory News (CMPG)

Share Price Information for Ct Global Grwth (CMPG)

Share Price is delayed by 15 minutes
Get Live Data
326.00    0.00 (0.00%)
Bid:
322.00
Ask:
330.00
Spread: 8.00 (2.484%)
Market Cap: £310.06m
CMPG Live PriceLast checked at - London Stock Exchange

Intraday Ct Global Grwth Share Chart

Directorate change

19 Feb 2026 11:08

RNS Number : 7012T
CT Global Managed Portfolio Trust
19 February 2026
 

To: RNS

From: CT Global Managed Portfolio Trust PLC

Date: 19 February 2026

LEI: 213800ZA6TW45NM9YY31

 

 

CT Global Managed Portfolio Trust PLC ('the Company')

 

Directorate Change

 

Appointment of Non-Executive Director and Chair of the Marketing Committee

Information disclosed in accordance with paragraph 6.4.6R of the Financial Conduct Authority's UK Listing Rules.

 

Following a formal recruitment process and a search conducted by an independent agency, the Board of the Company is pleased to announce the appointment of Roland Spencer as a non-executive director of the Company with effect from 19 February 2026. From this date, Roland will also chair the Marketing Committee, in place of David Warnock.

 

Roland has twenty-five years' experience in the financial sector, including eighteen years in the UK direct‑to‑consumer investments and platform market. His most recent role was Head of New Business at AJ Bell where he previously held a number of senior positions covering AJ Bell Media, corporate development, marketing and product proposition between 2012 to 2025. A recognised industry expert, Roland is a regular speaker at events on retail investor engagement.

 

Roland Spencer, and his Persons Closely Associated to him, do not own any Income shares or Growth shares in the Company and his election will be proposed to shareholders for approval at the Annual General Meeting of the Company currently scheduled to be held in September 2026.

 

There is no other information required to be disclosed pursuant to paragraph 6.4.8R of the Financial Conduct Authority's UK Listing Rules in relation to this appointment.

 

David Warnock, Chairman commented:

 

'We are delighted to welcome Roland as a non-executive director of the Company and believe that his experience of marketing, the direct-to-consumer market and retail investor engagement will add considerable value to the Board.'

 

 

For further information contact:

 

Ian Ridge

Columbia Threadneedle Investment Business Limited

Company Secretary

 

Tel: 0131 573 8300

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPURUPUPQGGB
Date   Source Headline
9th Dec 202512:41 pmRNSNet Asset Value(s)
8th Dec 202512:39 pmRNSNet Asset Value(s)
5th Dec 20251:00 pmRNSNet Asset Value(s)
4th Dec 20254:07 pmRNSPortfolio Update
4th Dec 202512:30 pmRNSNet Asset Value(s)
3rd Dec 20254:27 pmRNSIssue of Equity
3rd Dec 202512:35 pmRNSNet Asset Value(s)
2nd Dec 20254:34 pmRNSIssue of Equity
2nd Dec 202512:44 pmRNSNet Asset Value(s)
1st Dec 20251:15 pmRNSCompliance with Market Abuse Regulation
1st Dec 202512:35 pmRNSNet Asset Value(s)
1st Dec 202510:45 amRNSTotal Voting Rights
28th Nov 20255:04 pmRNSPortfolio Update
28th Nov 20254:32 pmRNSIssue of Equity
28th Nov 202512:58 pmRNSNet Asset Value(s)
27th Nov 20254:10 pmRNSIssue of Equity
27th Nov 202512:42 pmRNSNet Asset Value(s)
26th Nov 202512:41 pmRNSNet Asset Value(s)
25th Nov 20254:12 pmRNSIssue of Equity
25th Nov 202512:43 pmRNSNet Asset Value(s)
24th Nov 20254:20 pmRNSIssue of Equity
24th Nov 202512:49 pmRNSNet Asset Value(s)
21st Nov 20251:00 pmRNSNet Asset Value(s)
20th Nov 202512:37 pmRNSNet Asset Value(s)
19th Nov 20255:24 pmRNSIssue of Equity
19th Nov 202512:53 pmRNSNet Asset Value(s)
18th Nov 202512:48 pmRNSNet Asset Value(s)
17th Nov 202512:47 pmRNSNet Asset Value(s)
14th Nov 202512:48 pmRNSNet Asset Value(s)
13th Nov 20255:09 pmRNSTransaction in Own Shares
13th Nov 202512:28 pmRNSNet Asset Value(s)
12th Nov 20255:10 pmRNSTransaction in Own Shares
12th Nov 202512:45 pmRNSNet Asset Value(s)
11th Nov 202512:52 pmRNSNet Asset Value(s)
10th Nov 202512:45 pmRNSNet Asset Value(s)
7th Nov 202512:41 pmRNSNet Asset Value(s)
6th Nov 202512:32 pmRNSNet Asset Value(s)
5th Nov 202512:32 pmRNSNet Asset Value(s)
5th Nov 202511:10 amRNSConversion of Shares
4th Nov 202512:45 pmRNSNet Asset Value(s)
3rd Nov 202512:44 pmRNSNet Asset Value(s)
3rd Nov 202512:03 pmRNSTotal Voting Rights
31st Oct 202512:32 pmRNSNet Asset Value(s)
30th Oct 20251:00 pmRNSNet Asset Value(s)
29th Oct 20253:10 pmRNSTransaction in Own Shares
29th Oct 202512:56 pmRNSNet Asset Value(s)
28th Oct 20251:06 pmRNSNet Asset Value(s)
27th Oct 20254:57 pmRNSTransaction in Own Shares
27th Oct 202512:29 pmRNSNet Asset Value(s)
24th Oct 202512:56 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.